1048703-14-5

Basic information

• Product Name: (R)-tert-butyl (4-hydroxy-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate
• Synonyms: (R)-tert-butyl (4-hydroxy-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate
• CAS NO: 1048703-14-5
• Molecular Weight: 319.324
• Mol File: 1048703-14-5.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: (R)-tert-butyl (4-hydroxy-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-tert-butyl (4-hydroxy-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate(1048703-14-5)
• EPA Substance Registry System: (R)-tert-butyl (4-hydroxy-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate(1048703-14-5)

Safety Data

• Hazardous Substances Data: 1048703-14-5(Hazardous Substances Data)

Upstream product

• 1380243-15-1 C₁₁H₂₃NO₅ 
• 915715-25-2 (S)-(3-benzyloxy-1-hydroxymethyl-propyl)-carbamic acid tert-butyl ester 
• 1380298-42-9 C₁₂H₂₅NO₇S 
• 34619-03-9 tert-butyldicarbonate 
• 1056166-08-5 (2S)-2-(2-hydroxy-ethyl)-aziridine-1-carboxylic acid tert-butyl ester 
• 327-52-6 1-bromo-2,4,5-trifluorobenzene 
• 1380243-41-3 C₂₄H₂₄F₃NO 
• 680993-47-9 1-allyl-2,4,5-trifluorobenzene 
• 322691-00-9 2-(tert-butoxycarbonylamino)-butane-1,4-diyl dimethanesulfonate 
• 397246-14-9 (1-(hydroxymethyl)-3-hydroxypropyl)carbamic acid tert-butyl ester 
• 130622-08-1 (2R)-2-tert-butoxycarbonylamino-succinic acid dimethyl ester 
• 191655-45-5 (2S)‐2‐{[(tert‐butoxy)carbonyl]amino}‐4‐[(tert‐butyldimethylsilyl)oxy]butanoic acid 
• 1380298-41-8 C₁₅H₃₂BrNO₃Si 
• 1380298-40-7 C₂₂H₃₉NO₆SSi 

Downstream Products

• 1048703-15-6 tert-butyl (R)-(4-oxo-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate 
• 1500076-58-3 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)benzamide hydrochloride 
• 1500076-59-4 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)-2,3-difluorobenzamide hydrochloride 
• 1500076-60-7 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)-4-methoxybenzamide hydrochloride 
• 1500076-61-8 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)-4-(methylsulfonyl)-benzamide hydrochloride 
• 1500076-62-9 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)-4-sulfamoylbenzamide hydrochloride 
• 1500076-63-0 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)-4-(trifluoromethyl)benzamide hydrochloride 
• 1500076-64-1 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)-4-(1H-1,2,4-triazol-1-yl)benzamidehydrochloride 
• 1500076-65-2 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)-1H-benzo[d]imidazole-6-carboxamide hydrochloride 
• 1500076-66-3 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)-1H-benzo[d]-[1,2,3]triazole-6-carboxamide hydrochloride 
• 1500076-67-4 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)nicotinamide hydrochloride 
• 1500076-68-5 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)thiophene-3-carboxamide hydrochloride 
• 1500076-69-6 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)quinoline-6-carboxamide hydrochloride 
• 1500076-70-9 (R)-N-(3-amino-4-(2,4,5-trifluorophenyl)butyl)-2-phenylacetamide hydrochloride 

Relevant articles and documents

Preparation method of sitagliptin intermediate

The invention discloses a preparation method of a sitagliptin intermediate and belongs to the field of medicine synthesis. The invention provides a preparation method of a compound 2; the compound 2 is prepared without the need of a catalyst and a resolving agent which have a high price and harsh low-temperature conditions, so that the cost is reduced to the great extent; the preparation method has the advantages of simple technology, high purity and high yield and is suitable for mass production.

INTERMEDIATES OF SITAGLIPTIN AND PREPARATION PROCESS THEREOF

Disclosed are intermediates of Sitagliptin, a preparation process thereof, and a process for synthesizing Sitagliptin using these intermediates. Sitagliptin is synthesized by using chiral amino compounds as a raw material, without having to build a chiral center with a chiral asymmetric catalytic hydrogenation, and high-pressure hydrogenation is avoided.

INTERMEDIATES OF SITAGLIPTIN AND PREPARATION PROCESS THEREOF

Disclosed are intermediates of Sitagliptin, a preparation process thereof, and a process for synthesizing Sitagliptin using these intermediates. Sitagliptin is synthesized by using chiral amino compounds as a raw material, without having to build a chiral center with a chiral asymmetric catalytic hydrogenation, and high-pressure hydrogenation is avoided.